Patents by Inventor Jerome Kim

Jerome Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nucleic acids encoding human immunodeficiency virus type 1 (HIV-1) N-terminal deleted gp120 immunogens and methods of use
    Patent number: 11053285
    Abstract: The present invention relates, in general, to human immunodeficiency virus (HIV), and in particular to a vaccine for HIV-1 and to methods of making and using same.
    Type: Grant
    Filed: June 27, 2018
    Date of Patent: July 6, 2021
    Assignees: Duke University, THE GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE ARMY, Children's Medical Center Corporation
    Inventors: Jerome Kim, Stephen Harrison, Barton F. Haynes, Georgia D. Tomaras, Nelson Michael
  • Methods of inducing an immune response against HIV-1 using recombinant envelopes with improved coverage
    Patent number: 10906941
    Abstract: The present invention relates, in general, to human immunodeficiency virus-1 (HIV-1) particular, to a polyvalent vaccine for HIV-1 and to methods of making and using same.
    Type: Grant
    Filed: April 15, 2014
    Date of Patent: February 2, 2021
    Inventors: Jerome Kim, Morgane Rolland, Bette T. Korber, Barton F. Haynes
  • Methods for inducing an immune response against human immunodeficiency virus infection in subjects undergoing antiretroviral treatment
    Patent number: 10525123
    Abstract: Methods for inducing an immune response against Human Immunodeficiency Virus (HIV) in HIV-infected subjects undergoing antiretroviral therapy (ART) are described. The methods include administering an adenovirus vector primer vaccine and a modified vaccinia virus (MVA) vector booster vaccine encoding mosaic HIV antigens.
    Type: Grant
    Filed: April 16, 2019
    Date of Patent: January 7, 2020
    Assignees: Janssen Vaccines & Prevention B.V., Beth Israel Deaconess Medical Center, Inc., THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC., The Government of The United States, as represented by The Secretary Of The Army
    Inventors: Frank Tomaka, Maria Grazia Pau, Johanna Schuitemaker, Dan Barouch, Jintanat Ananworanich, Merlin Robb, Nelson L. Michael, Jerome Kim
  • METHODS FOR INDUCING AN IMMUNE RESPONSE AGAINST HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN SUBJECTS UNDERGOING ANTIRETROVIRAL TREATMENT
    Publication number: 20190247491
    Abstract: Methods for inducing an immune response against Human Immunodeficiency Virus (HIV) in HIV-infected subjects undergoing antiretroviral therapy (ART) are described. The methods include administering an adenovirus vector primer vaccine and a modified vaccinia virus (MVA) vector booster vaccine encoding mosaic HIV antigens.
    Type: Application
    Filed: April 16, 2019
    Publication date: August 15, 2019
    Inventors: Frank TOMAKA, Maria Grazia PAU, Johanna SCHUITEMAKER, Dan BAROUCH, Jintanat ANANWORANICH, Merlin ROBB, Nelson L. MICHAEL, Jerome KIM
  • Methods for inducing an immune response against human immunodeficiency virus infection in subjects undergoing antiretroviral treatment
    Patent number: 10307477
    Abstract: Methods for inducing an immune response against Human Immunodeficiency Virus (HIV) in HIV-infected subjects undergoing antiretroviral therapy (ART) are described. The methods include administering an adenovirus vector primer vaccine and a modified vaccinia virus (MVA) vector booster vaccine encoding mosaic HIV antigens.
    Type: Grant
    Filed: September 1, 2017
    Date of Patent: June 4, 2019
    Assignees: Janssen Vaccines & Prevention B.V., The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Beth Israel Deaconess Medical Center, Inc., The United States of America, as represented by The Secretary Of The Army
    Inventors: Frank Tomaka, Maria Grazia Pau, Johanna Schuitemaker, Dan Barouch, Jintanat Ananworanich, Merlin Robb, Nelson L. Michael, Jerome Kim
  • N-TERMINAL DELETED GP120 IMMUNOGENS
    Publication number: 20180305411
    Abstract: The present invention relates, in general, to human immunodeficiency virus (HIV), and in particular to a vaccine for HIV-1 and to methods of making and using same.
    Type: Application
    Filed: June 27, 2018
    Publication date: October 25, 2018
    Inventors: Jerome KIM, Stephen HARRISON, Barton F. HAYNES, Georgia D. TOMARAS, Nelson MICHAEL
  • Human immunodeficiency virus type 1 (HIV-1) N-terminal deleted GP120 immunogens
    Patent number: 10040826
    Abstract: The present invention relates, in general, to human immunodeficiency virus (HIV), and in particular to a vaccine for HIV-1 and to methods of making and using same.
    Type: Grant
    Filed: July 5, 2012
    Date of Patent: August 7, 2018
    Assignees: DUKE UNIVERSITY, THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE ARMY, CHILDREN'S MEDICAL CENTER CORPORATION
    Inventors: Jerome Kim, Stephen Harrison, Barton F. Haynes, Georgia D. Tomaras, Nelson Michael
  • Immunogens comprising human immunodeficiency virus V1/V2 polypeptides
    Patent number: 9988424
    Abstract: The invention is generally directed to V1V2 immunogens.
    Type: Grant
    Filed: December 5, 2012
    Date of Patent: June 5, 2018
    Assignees: DUKE UNIVERSITY, U.S. ARMY MEDICAL RESEARCH AND MATERIEL COMMAND, NEW YORK UNIVERSITY
    Inventors: Barton F. Haynes, Huaxin Liao, Jerome Kim, Nelson Michael, Susan B. Zolla-Pazner
  • METHODS FOR INDUCING AN IMMUNE RESPONSE AGAINST HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN SUBJECTS UNDERGOING ANTIRETROVIRAL TREATMENT
    Publication number: 20180064803
    Abstract: Methods for inducing an immune response against Human Immunodeficiency Virus (HIV) in HIV-infected subjects undergoing antiretroviral therapy (ART) are described. The methods include administering an adenovirus vector primer vaccine and a modified vaccinia virus (MVA) vector booster vaccine encoding mosaic HIV antigens.
    Type: Application
    Filed: September 1, 2017
    Publication date: March 8, 2018
    Inventors: Frank TOMAKA, Maria Grazia PAU, Johanna SCHUITEMAKER, Dan BAROUCH, Jintanat ANANWORANICH, Merlin ROBB, Nelson L. MICHAEL, Jerome KIM
  • POLYVALENT HIV-1 IMMUNOGEN
    Publication number: 20160115205
    Abstract: The present invention relates, in general, to human immunodeficiency virus-1 (HIV-1) particular, to a polyvalent vaccine for HIV-1 and to methods of making and using same.
    Type: Application
    Filed: April 15, 2014
    Publication date: April 28, 2016
    Inventors: Jerome Kim, Morgane Rolland, Bette T. Korber, Barton F. Haynes
  • ADCC-MEDIATING ANTIBODIES, COMBINATIONS AND USES THEREOF
    Publication number: 20150239961
    Abstract: The present invention relates, in general, to antibody-dependent cellular cytoxicity (ADCC)-mediating antibodies, and, in particular, to ADCC-mediating antibodies (and fragments thereof) suitable for use, for example, in reducing the risk of HIV-1 infection in a subject. The invention further relates to compositions comprising such antibodies or antibody fragments.
    Type: Application
    Filed: September 26, 2013
    Publication date: August 27, 2015
    Inventors: Barton F. Haynes, Mattia Bonsignori, Hua-xin Liao, Guido Ferrari, Michael A. Moody, Jerome Kim, Nelson Michael, Justin Pollara
  • V1V2 IMMUNOGENS
    Publication number: 20140335126
    Abstract: The present invention relates, in general, to human immunodeficiency virus (HIV), and in particular to a vaccine for HIV-1 and to methods of making and using same.
    Type: Application
    Filed: December 5, 2012
    Publication date: November 13, 2014
    Inventors: Barton F. Haynes, Huaxin Liao, Jerome Kim, Nelson Michael, Susan B. Zolla-Pazner
  • HERPES SIMPLEX VIRUS
    Publication number: 20140302062
    Abstract: The present invention relates, in general to herpes simplex virus (HSV) and, particular, to antibodies that are specific for glycoprotein D (gD) of HSV. The invention also relates to prophylactic and therapeutic uses of such antibodies.
    Type: Application
    Filed: April 9, 2012
    Publication date: October 9, 2014
    Applicants: U.S. ARMY MEDICAL RESEARCH AND MATERIEL COMMAND, DUKE UNIVERSITY
    Inventors: Barton F. Haynes, Hua-Xin Liao, M. Anthony Moody, Georgia D. Tomaras, Jerome Kim, Nelson Michael
  • N-TERMINAL DELETED GP120 IMMUNOGENS
    Publication number: 20140248311
    Abstract: The present invention relates, in general, to human immunodeficiency virus (HIV), and in particular to a vaccine for HIV-1 and to methods of making and using same.
    Type: Application
    Filed: July 5, 2012
    Publication date: September 4, 2014
    Applicants: DUKE UNIVERSITY, U.S ARMY MEDICAL RESEARCH AND MATERIEL COMMAND, CHILDREN'S MEDICAL CENTER CORPORATION
    Inventors: Jerome Kim, Stephen Harrison, Barton F. Haynes, Georgia D. Tomaras, Nelson Michael
  • Microwave monolithic integrated circuit with coplaner waveguide having silicon-on-insulator composite substrate
    Patent number: 5986331
    Abstract: A microwave monolithic integrated circuit includes a coplanar waveguide (CPW) formed by a composite silicon structure constituted by a relatively high resistivity substrate, a first oxide layer on the upper surface thereof, a relatively thin silicon layer formed on the surface of the first oxide layer, and a very thin second oxide layer formed on the surface of the thin silicon layer. The silicon layer and the first oxide layer on which it is formed constitutes a silicon-on-insulator or SOI structure. A metallic signal line and ground planes are bonded to the surface of the second oxide layer. The zone of the thin silicon layer which extends between the ground planes is doped with an active impurity to produce high conductivity therein. As a result, the electric component of a quasi-TEM wave traversing the waveguide is substantially restricted to the thin silicon layer and does not penetrate to the underlying bulk silicon substrate.
    Type: Grant
    Filed: May 30, 1996
    Date of Patent: November 16, 1999
    Assignee: Philips Electronics North America Corp.
    Inventors: Theodore James Letavic, Manjin Jerome Kim
  • Monolithic microwave circuit with thick conductors
    Patent number: 5652173
    Abstract: A monolithic microwave integrated circuit (MMIC) is produced by a method which forms multilevel conductive members, including thick low-loss metallic members. The low-loss metallic members are particularly useful for forming inductors and interconnecting circuit components. The MMIC is formed on a thick oxide layer of a silicon-on-insulator structure having a high-resistivity silicon substrate to inhibit RF interaction with the substrate.
    Type: Grant
    Filed: May 9, 1996
    Date of Patent: July 29, 1997
    Assignee: Philips Electronics North America Corporation
    Inventor: Manjin Jerome Kim